In addition, a chronic study with the mouse TfRMAb-EPO fusion protein in the PSAPP mouse model of AD demonstrated improved hematology safety as well as better behavioral and therapeutic indices compared with recombinant EPO alone [138]. The gene discussed is EPO; the disease is Alzheimer disease.